Evidence map›Paper›PMID 10436860›Full record

ReviewClinical reviews in allergy & immunology

The arachidonate 12/15 lipoxygenases. A review of tissue expression and biologic function.

D J Conrad

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical reviews in allergy & immunology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 95 citations in OpenAlex.

  1. Trial
  2. iScience · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Biochemical Characterization of 13-Lipoxygenases ofInternational journal of molecular sciences · 2021
    Article
  11. Influence of Lipoxygenase Inhibition on Glioblastoma Cell Biology.International journal of molecular sciences · 2020
    Article
  12. Article
  13. Eicosanoids and cancer.Clinics (Sao Paulo, Brazil) · 2018
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Bystander signaling via oxidative metabolism.OncoTargets and therapy · 2017
    Review
  19. Article
  20. Identification of 12/15-lipoxygenase as a regulator of axon degeneration through high-content screening.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

D J ConradDepartment of Medicine, San Diego Veterans Administration Medical Center, University of California, CA, USA.
United States Department of Veterans Affairs · US

Funding

MOLECULAR MECHANISMS OF 15-LIPOXYGENASE EXPRESSIONK08HL003108 · NHLBI · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI CONRAD, DOUGLAS J · 1994 to 1998
–
NHLBI NIH HHS KO8 HL03108
6 · The paper itself

Abstract

12/15-Lipoxygenase is a highly regulated lipid-peroxidating enzyme whose expression and arachidonic acid metabolites are implicated in several important inflammatory conditions including airway and glomerular inflammation as well as atherosclerosis. Tissue expression of the original 12/15-lipoxygenase is well characterized in reticulocytes, eosinophils, airway epithelial cells, and monocytes/macrophages and is likely in other cell systems and tissues under specific conditions. The physiologic role of this family of enzymes is dependent on the context in which it is expressed. In general, the arachidonic acid metabolites antagonize inflammatory responses and counteract the proinflammatory effects of the 5-lipoxygenase pathway. However, certain diHETEs are associaled with pro-inflammatory effects, specifically neutrophilic and eosiniphilic chemotaxis. The direct action of these enzymes on complex lipids and cellular membranes also links them to such significant process as reticulocyte maturation, LDL oxidation in atherosclerosis and pulmonary host defenses. The availability of new specific inhibitors and murine lines that lack expression of the homologous 12-lipoxygenase will allow confirmation of many of these effects with in vivo models of inflammation.

Indexed as

AnimalsArachidonate 12-LipoxygenaseArachidonate 15-LipoxygenaseHumansOrgan SpecificityArachidonate 12-LipoxygenaseArachidonate 15-Lipoxygenase

Identifiers

PMID10436860
OpenAlexW1969846721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.